Table 1. Summary of FDA-approved GLP-1RAs.

Generic name	Brand name	Approval year
Exenatide	Bydureon, Bydureon Bcise, Byetta	2005
Liraglutide	Saxenda, Victoza	2009
Albiglutide	Eperzan, Tanzeum	2014
Dulaglutide	Trulicity	2014
Lixisenatide	Adlyxin, Lyxumia	2013
Semaglutide	Ozempic, Rybelsus	2017

FDA, Food and Drug Administration; GLP-1RAs, glucagon-like peptide-1 receptor agonists.